11C labelling of AG957 -: a potential tyrphostin radiotracer for PET

被引:6
作者
Ackermann, U
Tochon-Danguy, HJ
Young, K
Sachinidis, JI
Chan, JG
Scott, AM
机构
[1] Austin & Repatriat Med Ctr, Ctr PET, Heidelberg, Vic 3084, Australia
[2] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia
关键词
PET; tyrphostins; AG957; chronic myeloid leukaemia; carbon-11;
D O I
10.1002/jlcr.546
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Carbon-11 labelled 4-(N-2,5-dihydroxybenzyl)amino methyl benzoate (AG957), a potential radiotracer for imaging ber-abl receptors was synthesized. [C-11]AG957 was prepared by labelling 4-aminobenzoic acid using [C-11]CH3I, which affords the corresponding [C-11] methyl ester in excellent yields. Subsequent condensation of the amino group with 2,5-dihydroxybenzaldehyde formed the respective Schiff base. Reduction of this compound with NaBH3CN gave [C-11]AG957 in overall decay corrected radiochemical yield of 65-75% (based on (CH3I)-C-11) with an average specific radioactivity of 40 GBq/mumol (1.1 Ci/mumol). The total synthesis time from EOB including formulation was 45 min. At physiological pH, the compound was found to be sufficiently stable for in vitro and in vivo investigations. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:157 / 165
页数:9
相关论文
共 11 条
[1]  
Ackermann U., 2001, Journal of Labelled Compounds and Radiopharmaceuticals, V44, pS307
[2]  
ANAFI M, 1992, J BIOL CHEM, V267, P4518
[3]   Synthesis of two optically active calcium channel antagonists labelled with carbon-11 for in vivo cardiac PET imaging [J].
Dolle, F ;
Hinnen, F ;
Valette, H ;
Fuseau, C ;
Duval, R ;
Peglion, JL ;
Crouzel, C .
BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (04) :749-764
[4]   TYRPHOSTINS .1. SYNTHESIS AND BIOLOGICAL-ACTIVITY OF PROTEIN TYROSINE KINASE INHIBITORS [J].
GAZIT, A ;
YAISH, P ;
GILON, C ;
LEVITZKI, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (10) :2344-2352
[5]   TYRPHOSTINS .2. HETEROCYCLIC AND ALPHA-SUBSTITUTED BENZYLIDENEMALONONITRILE TYRPHOSTINS AS POTENT INHIBITORS OF EGF RECEPTOR AND ERBB2/NEU TYROSINE KINASES [J].
GAZIT, A ;
OSHEROV, N ;
POSNER, I ;
YAISH, P ;
PORADOSU, E ;
GILON, C ;
LEVITZKI, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (06) :1896-1907
[6]   LOCALIZATION OF THE C-ABL ONCOGENE ADJACENT TO A TRANSLOCATION BREAK POINT IN CHRONIC MYELOCYTIC-LEUKEMIA [J].
HEISTERKAMP, N ;
STEPHENSON, JR ;
GROFFEN, J ;
HANSEN, PF ;
DEKLEIN, A ;
BARTRAM, CR ;
GROSVELD, G .
NATURE, 1983, 306 (5940) :239-242
[7]  
Lemaire C., 1995, Journal of Labelled Compounds and Radiopharmaceuticals, V37, P723
[8]  
LEVITZKI A, Patent No. 94
[9]  
Taylor GF, 1996, J LABELLED COMPD RAD, V38, P187, DOI 10.1002/(SICI)1099-1344(199602)38:2<187::AID-JLCR832>3.0.CO
[10]  
2-3